A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

NCT05858749 · clinicaltrials.gov ↗
COMPLETED
Status
494
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer